Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jan-Mar;6(1):29-33.
doi: 10.4103/2249-4863.214954.

Profile of drug-resistant tuberculosis in Western Maharashtra

Sudhakar W More  1 , Malangori Abdulgani Parande  2 , Sanjeev W Kamble  3 , Manjunath S Kamble  4
Affiliations

Profile of drug-resistant tuberculosis in Western Maharashtra

Sudhakar W More et al. J Family Med Prim Care. 2017 Jan-Mar.

Abstract

Context: Drug-resistant tuberculosis (TB) strains have evolved mainly due to incomplete or improper treatment of TB patients and are one of the hurdles in controlling TB problem. It is better to understand the magnitude and comorbidities associated with drug-resistant TB.

Aim and objectives: (1) To study some of the sociodemographic profile and history of TB treatment of drug-resistant TB cases. (2) To study their drug-resistance pattern and their comorbidity profile.

Settings and design: It was a record-based study descriptive, cross-sectional study of drug-resistant TB cases that were referred to State TB Training and Demonstration Centre (STDC).

Materials and methods: The data were collected by means of use of TB patient treatment register of those tested at STDC during first two quarters of the year 2012 (from January to June 2012). Sputum samples of all the cases were subjected to concentrated microscopy, and all positive samples were tested by GeneXpert and Line Probe Assay for drug susceptibility testing (DST) for isoniazid and rifampicin.

Statistical analysis: The findings were analyzed with Epi info7, using the mean, standard deviation, Chi-square test.

Results: The mean age of the patients was 35.65 ± 13.59 years, majority 71.87% were males. The majority of patients 72.91% had the previous history of TB. A majority 68.75% of the patients had acquired drug resistance, and 73.95% of cases were suffering from multidrug-resistant TB. A total of 28.13% patients had self-reported comorbidity. A majority 62.5% had failure as the treatment outcome for the current episode of TB and mortality was seen in 12.5% cases.

Conclusions: Majority had failure as a treatment outcome due to advanced disease status or late diagnosis. Rapid diagnosis and DST for first- and second-line drugs will greatly improve the clinical outcome.

Keywords: Acquired drug resistance; initial drug resistance; multidrug-resistant tuberculosis; tuberculosis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
History of tuberculosis
See this image and copyright information in PMC

References

    1. Multi-Drug Resistant and Extensively Drug Resistant TB in India, Consensus Statement on the Problem, Prevention, Management and Control; From the Consultative Meeting of National Experts Organized by the TB Research Centre, ICMR, Government of India, on 14-15 September, 2007, at Chennai. 2007
    1. Government of India, DOTS-Plus Guidelines, January 2010, Ministry of Health and Family Welfare, New Delhi. 2010
    1. WHO. Global Tuberculosis Report 2015. 20th ed. Geneva: WHO; 2015.
    1. Government of India, TB INDIA 2015, RNTCP Annual Status Report, Ministry of Health and Family Welfare, New Delhi. 2015
    1. [Last accessed on 2016 Jun 24]. Available from: https://www.arogya.maharashtra.gov.in .